This global role will lead the medical evidence strategy for the RSV adult vaccines asset, focusing on vaccine effectiveness and burden studies, with a worldwide focus including support for Asia
Job Summary
This global role will lead the medical evidence strategy for the RSV adult vaccines asset, focusing on vaccine effectiveness and burden studies, with a worldwide focus including support for Asia.
Responsibilities include designing post-authorization epidemiology studies, ensuring methodological harmonization, overseeing regulatory interactions for vaccine effectiveness studies, and providing technical oversight for study execution.
The position offers a base salary range of $230,900.00 to $384,800.00, eligibility for a 25.0% bonus target, and participation in a long-term incentive program, along with comprehensive benefits.
Matching Summary
This global role will lead the medical evidence strategy for the RSV adult vaccines asset, focusing on vaccine effectiveness and burden studies, with a worldwide focus including support for Asia.
Salary
Base: $230,900.00 - $384,800.00; Bonus/Equity: 25.0% bonus target and share based long term incentive program; Benefits: Comprehensive and generous benefits and programs
Skills & Requirements
Must-have
RSV adult vaccine medical evidence strategy
vaccine effectiveness and burden studies
epidemiological methods
regulatory interactions
external partner relationships
viral respiratory disease expertise
Nice-to-have
post-authorization efficacy studies
adverse events assessments
cross-cultural leadership
matrixed team participation
Key Requirements
PhD with expertise in vaccinology and epidemiology
10+ years in vaccine-related medical/scientific activities
Lead or senior author of at least 5 peer-reviewed publications
Principal or lead investigator for at least two major projects
Presenting author for at least 5 abstracts at international scientific congresses
Demonstrated ability to manage projects to completion